Jane Thompson

Jane Thompson

Auto-generated profile, based on publicly available information

Jane Thompson

Univ Adelaide, South Australian Med Res Inst, Adelaide, SA 5000, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SPSant-Rayn Pasricha
Sant-Rayn Pasricha
MLMichael Low
Michael Low
JTJane Thompson
Jane Thompson
AFAnn Farrell
Ann Farrell
LDLuz-Maria De-Regil
Luz-Maria De-Regil
Animal and human observational studies suggest that iron deficiency impairs physical exercise performance, but findings from randomized trials on the

1 April 2013 in Pediatrics
Verified
Journal Article
Closed access
PDF file
JTJane Thompson
Jane Thompson
BBBeverley-Ann Biggs
Beverley-Ann Biggs
SPSant-Rayn Pasricha
Sant-Rayn Pasricha
BACKGROUND AND OBJECTIVES: Iron deficiency (ID) is the most common cause of anemia worldwide. The prevalence is highest among preschool-aged children. Iron is widely administered to children with or at risk for ID, but evidence of benefit among 2- to 5-year-old children has not been evaluated by systematic review. We summarize the evidence for the benefit and safety of daily iron supplementation with regard to hematologic, growth, and cognitive parameters in 2 to 5 year olds. METHODS: Electronic databases, regional databases, thesis repositories, gray literature, and references of studies and previous reviews were searched. We included randomized controlled trials that compared daily oral iron supplementation with control in 2 to 5 year olds. A random-effects meta-analysis was used to synthesize predefined outcomes reported by at least 2 studies. RESULTS: Of 9169 references, 15 studies met the inclusion criteria, none of which were at low risk of bias. Children receiving iron supplementation had a mean end point hemoglobin of 6.97 g/L (P < .00001; I2 = 82%) greater than controls, whereas mean end point ferritin was 11.64 µg/L (P < .0001; I2 = 48%) greater. No trials reported the effects of iron supplementation on ID or iron deficiency anemia, and only one reported on anemia. Limited evidence suggested that iron supplementation produced a small improvement in cognitive development but had no effect on physical growth. CONCLUSIONS: In 2 to 5 year olds, daily iron supplementation increases hemoglobin and ferritin. There is a concerning lack of data on the effect of iron supplementation on clinically important outcomes including anemia, ID anemia, ID, and cognitive development. Additional interventional studies in this age group are needed.

1 June 2000 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
JTJane F Thompson
Jane F Thompson
MCMarian J Currie
Marian J Currie
DEDavid Alan Ellwood
David Alan Ellwood
CRChristine L Roberts
Christine L Roberts
Objectives To determine whether women discharged from hospital ≤ 72 hours after childbirth (early discharge) were at greater risk of developing symptoms of postnatal depression during the following ...

7 July 2014 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
JTJ. Thompson
J. Thompson
SPS. Pavord
S. Pavord
KLK. Lim
K. Lim

31 January 2020 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
JTJane F. Thompson
Jane F. Thompson
ZTZoe Teh
Zoe Teh
YCYiyang Chen
Yiyang Chen
JGJoanne Gardiner
Joanne Gardiner
JBJana M. Bednarz
Jana M. Bednarz
DYDavid Yeung
David Yeung
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

7 September 2024 in Pathology
Verified
Journal Article
Open access
JTJane Thompson
Jane Thompson
GTGeoffrey Thompson
Geoffrey Thompson
DWDeborah White
Deborah White
DYDavid Yeung
David Yeung
Diagnosis of Philadelphia chromosome-like acute lymphoblastic leukaemia (Ph-like ALL) in the real-world remains challenging because of definitional complexities, the diverse diagnostic techniques available and the cost, expertise and time involved. We summarise evidence for diagnosis of clinically important Ph-like ALL related genomic lesions using fluorescence in situ hybridisation (FISH) targeting only clinically important and actionable lesions, an accessible and cost-effective diagnostic technique. Electronic databases were interrogated using broad MeSH terms for articles reporting a detailed FISH strategy for diagnosis of Ph-like ALL published since 2014, yielding 653 full text articles and abstracts. We searched the National Library of Medicine Databases including PubMed, Medline, Embase, Cochrane and relevant abstracts. We included studies with a primary aim of determining the utility of FISH for Ph-like ALL diagnosis and studies with broader aims demonstrating Ph-like ALL diagnostic algorithms which partially involved FISH. Nineteen studies met inclusion criteria. Evidence for FISH to detect CRLF2 rearrangements in Ph-like ALL is strongly established and evidence for FISH to detect non-CRLF2 lesions is evolving rapidly. We documented 1620 cases of non-CRLF2 Ph-like lesions diagnosed by FISH. Confirmatory side-by-side methods were applied in six studies (246 samples), four of which demonstrated 100% concordance of FISH results with alternative methods, while two studies demonstrated over 70% sensitivity and specificity. Additional studies demonstrated wide utilisation of FISH in Ph-like ALL classification across diverse geographies and ethnicities, with contrasting prevalence, implicating a need for targeted FISH strategies. In real-world cohorts, it may be clinically useful to prioritise limited early FISH in B-cell ALL (B-ALL) diagnostic algorithms to identify Ph-like abnormalities that respond to locally available kinase inhibitors to promote and prioritise broad access to effective targeted treatment. Additional studies are required to provide adequately powered validations and verifications of targeted Ph-like FISH panels to confirm sensitivity and specificity against side-by-side gold standard methods, and to define optimal local approaches.